Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation

Area of Science:

• Hematology
• Oncology
• Cytogenetics

Background:

• Cytogenetic abnormalities are infrequent in essential thrombocythemia (ET).
• Their prognostic significance for survival and disease transformation in ET is not well-established.
• Understanding these abnormalities is crucial for patient management.

Purpose of the Study:

• To describe the incidence and types of cytogenetic abnormalities in ET patients.
• To evaluate the impact of cytogenetic changes on patient survival.
• To assess the role of cytogenetic monitoring during follow-up for disease transformation.

Main Methods:

• Retrospective analysis of cytogenetic data from 172 ET patients.
• Karyotyping performed at presentation and during follow-up.
• Correlation of cytogenetic findings with clinical outcomes, including survival and transformation.

Main Results:

• Cytogenetic abnormalities were found in 5.2% at presentation and 1.7% acquired during follow-up.
• No significant difference in survival was observed between patients with and without cytogenetic changes.
• Common abnormalities involved chromosomes 9, 20, 5, and complex rearrangements.
• Transformation to myelofibrosis, myelodysplastic syndrome, or acute myeloid leukemia occurred in a small subset, with some acquiring new changes.

Conclusions:

• Cytogenetic abnormalities are uncommon in ET and do not appear to affect survival.
• Routine cytogenetic monitoring during follow-up is not indicated unless hematologic changes suggest transformation.
• Further research may clarify the role of specific complex abnormalities in disease progression.